Exact Sciences CorporationEXASNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

25 analysts·High coverage

48%

Rating Distribution

Strong Buy

00%

Buy

1248%

Hold

1352%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 4% above analyst consensus — near fair value expected.

Bear Case

$46.00

-55%

Consensus

$98.42

-4%

Bull Case

$105.00

+2%

Price Range25 analysts

Low

Consensus

High

$46.00

$105.00

Current Target

Current Price

$102.53

Above Target

$4.11

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.38(8 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+12.93%

EPS+259.08%

FY2028

Rev+9.13%

EPS+32.98%

FY2029

Rev+9.75%

EPS+5.07%

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+175.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 20, 2026Mizuho Securities

Exact Sciences downgraded to Neutral from Outperform at Mizuho

Target:$105.00

+2.5%from $102.43

Jan 5, 2026Evercore ISI

Exact Sciences downgraded to In Line from Outperform at Evercore ISI

Target:$105.00

+3.2%from $101.74

Nov 28, 2025Stifel Nicolaus

Exact Sciences downgraded to Hold from Buy at Stifel

Target:$105.00

+3.7%from $101.29

Nov 25, 2025Canaccord Genuity

Exact Sciences downgraded to Hold from Buy at Canaccord

Target:$105.00

+4.0%from $101.01

Nov 24, 2025Piper Sandler

Exact Sciences downgraded to Neutral from Overweight at Piper Sandler

Target:$105.00

+4.0%from $101.00

Nov 24, 2025Jefferies

Jefferies Downgrades Exact Sciences (EXAS) to Hold

Target:$105.00

+4.1%from $100.90

Nov 21, 2025Craig-Hallum

Exact Sciences downgraded to Hold from Buy at Craig-Hallum

Target:$105.00

+4.3%from $100.67

Nov 20, 2025Barclays

Exact Sciences downgraded to Equal Weight from Overweight at Barclays

Target:$105.00

+4.3%from $100.67

Nov 20, 2025Wells Fargo

Exact Sciences downgraded to Equal Weight from Overweight at Wells Fargo

Target:$105.00

+21.8%from $86.18

Nov 20, 2025Robert W. Baird

Exact Sciences downgraded to Neutral from Outperform at Baird

Target:$105.00

+3.6%from $101.34

Nov 4, 2025Robert W. Baird

Exact Sciences price target raised to $88 from $72 at Baird

Target:$88.00

+22.1%from $72.06

Nov 4, 2025BTIG

Exact Sciences price target raised to $85 from $75 at BTIG

Target:$85.00

+26.9%from $66.98

Nov 4, 2025Stifel Nicolaus

Exact Sciences price target raised to $80 from $67 at Stifel

Target:$80.00

+19.4%from $66.98

Nov 4, 2025Barclays

Exact Sciences price target raised to $77 from $65 at Barclays

Target:$77.00

+15.0%from $66.98

Oct 8, 2025Piper Sandler

Exact Sciences price target raised to $70 from $60 at Piper Sandler

Target:$70.00

+21.2%from $57.75

Oct 7, 2025Evercore ISI

Exact Sciences price target, added to 'Tactical Outperform' list at Evercore ISI

Target:$68.00

+18.0%from $57.63

Oct 2, 2025Barclays

Exact Sciences price target raised to $65 from $55 at Barclays

Target:$65.00

+15.2%from $56.43

Oct 1, 2025Wells Fargo

Exact Sciences added to Q4 2025 Tactical Ideas List at Wells Fargo

Target:$68.00

+24.3%from $54.71

Aug 7, 2025RBC Capital

Exact Sciences (EXAS) PT Lowered at RBC Capital on 'Long Term Uncertainty'

Target:$46.00

+11.3%from $41.34

Mar 28, 2025Guggenheim

Exact Sciences price target lowered to $60 from $73 at Guggenheim

Target:$60.00

+33.4%from $44.99

Jan 2, 2025Evercore ISI

Exact Sciences price target raised to $70 from $60 at Evercore ISI

Target:$70.00

+23.0%from $56.93

Nov 6, 2024Robert W. Baird

Exact Sciences (EXAS) PT Lowered to $67 at Baird

Target:$67.00

-7.5%from $72.42

Nov 6, 2024BTIG

Exact Sciences (EXAS) PT Lowered to $65 at BTIG

Target:$65.00

-10.2%from $72.42

Oct 29, 2024Canaccord Genuity

Exact Sciences (EXAS) PT Raised to $95 at Canaccord Genuity

Target:$95.00

+37.0%from $69.35

Oct 1, 2024Evercore ISI

Exact Sciences price target raised to $80 from $72 at Evercore ISI

Target:$80.00

+17.4%from $68.12

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance